There is now a convincing body of evidence that mechanism of atherosclerosis has a major inflammatory component and it is much more than the simple accumulation of lipids on the vascular walls. Studies have shown that certain other mild bacterial infections consist a major risk factor for stroke in young and middle aged patients.
INTRODUCTION
The term "periodontal diseases" has been used for years to include all diseases of the soft and hard tissue surrounding the teeth (i.e. the periodontium), including gingivitis, which is a reversible infection of the soft tissue without permanent loss of periodontal support. Chronicperiodontitis, henceforth referred to as PD, is a chronic bacterial infection that causes a persistent host inflammatory response with destruction of the bone and soft tissue surrounding teeth, leading to tooth mobility and ultimately to loss of teeth [1] . Periodontitis is an inflammatory disease of the gums, which affects all the dental supporting tissues. It has been mentioned that severe generalized periodontal disease is present in 8% to 13% of the world's adult population [2] . The prevalence is lower in children and young adults with an estimated rate 2% to 5% between the ages of 11 and 25 being affected [3] . Periodontitis is a progressive inflammation, leading to the destruction of the supporting tissue and alveolar bone loss. This process is the result of the bacteria -produced toxins and the inflammatory reaction of the gum tissues [4] . Today, the available evidence does allow us an interpretation of periodontitis being a risk factor for atherosclerosis coronary heart disease [5] .
Cardiovascular disease occurs as a result of a complex set of genetic and environmental factors. The genetic factors include age, hypertension, diabetes, marked obesity, lipid metabolism, fibrinogen levels and platelet P1 polymorphism. The environmental risk factors include diet, physical inactivity, stress, cigarette smoking, socioeconomic status, chronic infections, use of non-steroid anti-inflammatory drugs and possible endothelial cell injury. Cardiovascular mortality rates account for about 30% of all deaths, despite efforts aiming at controlling the conventional risk factors. The identification of factors leading to an increased risk of coronary heart disease is still far from complete. It has been estimated that, to a significant percentage of patients with the disease, no one of the established risk factors aforementioned, does apply [6] . Periodontal disease is colonized by a number of gram-positive and gram-negative bacteria that have been shown to affect the initiation and development of periodontal disease and have been associated with the potential etiological role of periodontal disease in cardiovascular disease and other chronic conditions [7] . Inflammation plays a crucial role in all stages of the development of the atherosclerotic lesion. This 'inflammation hypothesis' raises the possibility that through systemic elevations of pro-inflammatory cytokines, periodontal diseases might also contribute to systemic inflammation and, therefore, to atherogenesis. In fact, there is evidence that periodontal diseases are associated with higher systemic levels of high-sensitivity C-reactive protein and a low grade systemic inflammation. This phenomenon has been explained based on mechanisms associated with either the infectious or the inflammatory nature of periodontal diseases [8] . In this paper, we examine the evidence for an association between periodontal infections and increased risk of cardiovascular disease and we also study the connection between periodontal infections and its treatment modalities.
Possible role of dental infections in the etiopathogenesis of cardiovascular diseases
Oral flora is normally confined in the mouth, located on the surfaces of the tongue, gingiva, mucous membranes and teeth. Periodontal pathogens, invade epithelial cells and connective tissue causing periodontal inflammation and bleeding which enables entry of oral flora, including non-invasive organism, into the blood stream and transportation to systemic locales. Procedures such as dental extraction, periodontal surgery, tooth scaling and even the brushing of teeth often lead to the presence of oral bacteria in the blood stream (bacteremia). There is evidence that common oral hygiene practices daily produce low-level bacteremia [9] .
Certain oral bacteria are known as causative agents associated to infective endocarditis [10] . Furthermore, dental bacteremias associated to periodontitis are considered as risk factors for coronary heart disease and stroke. Atherosclerotic plaque samples are often found infected with multiple infectious agents, as Porphyromonas gingivalis and Streptococcus sanguis, which are common in periodontal disease. The immunolocalization of these microorganisms within unstable plaque regions and their association with plaque ulceration, thrombosis and apoptosis in vascular cells, are intriguing. Multiple infectious agents may alter vascular cell function and provide the possibility for acute ischemic stroke events [11] . Streptococcus sanguis is the most prevalent species in dental plaque [12] and frequently identified in the polymicrobial bacteremia form dental foci. Platelet aggregating strains (Agg+) of Streptococcus sanguis are found to induce aggregation of human platelets in vitro [13] . This phenomenon is mediated by the expression of the platelet aggregation-associated protein (PAAP) on the surface of certain strains [14] . The PAAP is a collagenlike cell surface antigen containing the sequence KPGEPGK58. This sequence forms a structural motif common in all known platelet-interactive domains of collagens. In experimental studies on rabbits, PAAP was found to induce the formation of platelet vegetation during endocarditis [15] . Following infusion of Agg+ Streptococcus sanguis, platelets and fibrin accumulation on injured heart valves, was observed. To verify that valvular vegetation was indeed thrombi, rabbits were treated to inhibit formation of digest platelet-associated fibrin. The eventual mass of the vegetation was reduced by pretreatment with monospecific rabbit antifebrin antibody or by therapy with recombinant human tissue plasminogen activator. When present in the circulation, Agg+ Streptococcus sanguis may also induce thromboembolic events. The Agg+ phenotype may be associated with the occurrence of disseminated intravascular coagulation-like syndrome in immunocompromised patients [16] . Approximately 60% of human isolates express the Agg+ phenotype. Studies have shown that infusion of Agg+ colony strains causes a rise in blood pressure, heart rate, increased cardiac contractility and chances in electrocardiograms (ECGs) in rabbits [17] . Inflammatory cells and the inflammatory mediators such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and prostaglandin E2 (PGE2) play a key role in human coronary heart disease and atherosclerosis [18] . Bacterial LPS initiates the expression of IL-1b, which impedes fibrilonysis but facilitates coagulation and thrombosis. Cytokines enhance both cholesterol accumulation in monocytes and smooth muscle proliferation, which presumably results in thickening of vessel walls [19] . Thus, the pathway LPS, moncyte activation, inflammatorymediator production is implicated as an important mechanism in the pathogenesis of coronary heart disease and atherosclerosis. Today, the existence of inflammatory response in the process of the periodontal disease has been proved [20] . Monocytes within the periodontal tissues respond to LPS production of the plaque organisms by secreting important proinflammatory mediators, such as TNF-α, IL-1b, PGE2, and thromboxane A2 (TxA2), which not only cause local effects in the periodontal tissues, but may appear systemically [18] . Periodontal disease, like ischemic heart disease involves the above shown pathway [5] . The systemic response to oral pathogens is a result of bacterial penetration into tissues, loss of integrity of the epithelium in the periodontal sulcus and transient dental bacteremia. It has been shown that endotoxins of plaque microorganisms are capable of penetrating the gingival tissues and entering into the blood stream, in amounts sufficient to bring about a systemic LPSspecific antibody response [21] .
Epidemiological studies showing an association between cardiovascular disease and periodontitis
One of the earliest epidemiological studies by Matilla et al reported that dental health, including periodontal health, was significantly worse in patients with acute myocardial infarction than in controls [22] . In a study by DeStefano et al, participants who had periodontitis had a 25% increased risk of CHD relative to those with minimal periodontal disease [23] . Persson et al studied clinical periodontal conditions, alveolar bone loss, selfreported medical histories, and carotid calcifications from panoramic radiographs in older adults [24] . They found an odds ratio of 2:1 for carotid calcifications and periodontitis. In another study based on a subset of participants in the atherosclerosis risk in communities study, Beck et al concluded that clinical signs of periodontal disease were not associated with CHD but that systemic antibody response was associated with CHD in smokers and nonsmokers alike [25] .
Geismar et al studied the association of periodontal disease and CHD and attempted to explore common risk factors [26] . They found a strong association between periodontal disease and CHD in subjects under the age of 60. They also reported that this association could be attributed, to some extent, to diabetes and smoking. A similar finding was reported in a recent study by Dietrich et al. [27] . In subjects followed for up to 35 years, chronic periodontitis was associated with CHD among men under the age of 60, independent of established cardiovascular risk factors.
Longitudinal studies evaluating the effect of periodontal therapy on inflammatory markers
Several reports have shown increased serum CRP levels associated with periodontal disease severity. Ebersole et al conducted the initial study measuring serum CRP and heptoglobin levels in patients with periodontal disease [28] . Patients with the most severe disease demonstrated nearly a 17-fold increase in CRP levels compared to controls. Their results showed that mechanical debridement did not lower serum CRP levels; however, there was a decrease in heptoglobin levels measured at 12 months. Patients taking 50 mg of the anti-inflammatory drug flubiprofen displayed decreased levels of CRP over a two-year period.
A number of studies have demonstrated that nonsurgical periodontal therapy led to a decrease in serum CRP at selective times, in conjunction with improved clinical periodontal parameters and endothelial function.
The first study to report a decrease in serum CRP levels following nonsurgical periodontal treatment was conducted by Mattilla et al. [22] They noted a generalized decrease in CRP in the entire population; however, post-treatment CRP levels did not decrease significantly in all participating subjects, suggesting that patient susceptibility could play a crucial role.
D'Aiuto et al treated patients with nonsurgical mechanical therapy, recording serum CRP levels at baseline and at two and six months post-treatment [29, 30] . They noted that subjects with better clinical responses to periodontal treatment resulted in a greater decrease in CRP levels. They also recorded a statistically significant decrease in serum CRP at six months but not at two months. They determined that patients who responded better to periodontal therapy were four times more likely to reduce their risk category for cardiovascular disease.
Yamazaki et al conducted a study with Japanese subjects who displayed baseline levels of serum CRP much lower than those in Western populations with the same severity of periodontal disease [31] . These subjects received nonsurgical mechanical debridement, surgical intervention when indicated, and four days of nonspecified antibiotics. Results showed a trend for decreased CRP levels after treatment.
Pitiphat et al conducted a study in a Thai population that displayed lower basal levels of serum CRP compared to Western populations [32] . Serum CRP levels correlated with severity of periodontal disease. This study demonstrated that periodontal infection with P. gingivalis could contribute to a systemic inflammatory burden and elevated serum CRP in otherwise healthy individuals.
Tonetti et al compared periodontal treatment outcomes and endothelial function [33] . Improvement of endothelial function was related to reduction in the number of periodontal lesions. Patients underwent intensive, nonsurgical therapy, resulting at 24 hours in endothelial dysfunction, a decrease in endothelial flow, and an increase in inflammatory markers, including CRP. However, six-month post-treatment CRP levels decreased and patients showed improved endothelial function and an increase in endothelial flow rate.
Desvarieux et al reported smoking to be among potential effect modifiers of the periodontal infection/atherosclerotic vascular disease association.
Two publications from the normative aging study (NAS) cohort reported positive associations between periodontal disease and coronary artery disease [34] .
Recently reported data from Korea and India appear to be among the first publications reporting on associations between periodontal disease and clinical atherosclerotic vascular disease events in Asian populations. These data reinforce previous findings that stem predominantly from European and North American cohorts. The growing diversity of study populations from which results have been reported helps to assuage concerns about spurious findings related to health behaviors (smoking, dietary patterns, and physical activity), health care systems (access to care, clinical guidelines, availability of pharmaceuticals), and environment (tobacco, smoke, pollution, diet) [35, 36] .
A recent gene association study identified a common genetic susceptibility locus, shared by both CHD and aggressive periodontitis, that could partially account for observed associations. Unfortunately, very little, if anything, can be done in observational studies to account for this possibility. The remedy for this problem lies in randomization, a key feature of intervention studies testing the oral infection/atherosclerotic vascular disease hypothesis [37] . Results from studies using exposure definitions based on antibody titers also need to consider the influence of partial or complete edentulism, because edentulous participants, despite a likely history of periodontal infection, tend to display lower antibody titers compared to their dentate counterparts [38] .
Periodontal treatment modalities for various cardiovascular diseases
Safe periodontal care is accomplished by obtaining a thorough medical history and physical examination to identify symptoms and signs of cardiac diseases and by obtaining cardiology consultation if indicated. the increased incidence of periodontal diseases in elderly individuals indicate that periodontists must be prepared to provide periodontal care for increasing numbers of cardiovascular patients. For periodontists, the following are the commonest cardiovascular diseases which need to be taken into account: cardiac arrhythmias, coronary artery disease, myocardial infarction, hypertension, and heart transplantation [39] .
Cardiac arrhythmias
Cardiac arrhythmias may be caused by a variety of reversible abnormal physiologic events such as hypoxia or electrolyte/acid-based abnormalities. Other important causes are myocardial ischemia, increased sympathetic activity, and congestive heart failure. Some antiarrhythmic drugs cause xerostomia, gingival hyperplasia and blood dyscrasias as their side effects, which can contribute to the development as well as increase the severity of periodontal diseases. Some arrythmias need pacemakers, which are mostly implanted transvenously. Until now, the American heart Association (AHA) does not recommend prophylactic antibiotic coverage for dental procedures in pacemaker patients. During a dental procedure, the pacemaker maybe disrupted by external electrical Another potential risk for patients with a pacemaker is their disruption by external electrical fields such as those generated by powerful magnets during a dental procedure. Pacemaker disruption was a major problem with older models which were unipolar and not well insulated. The newer generation of pacemakers are bipolar and well insulated so the small amount of electromagnetic radiation generated by dental equipments pose little threat to their functions. Information regarding the type of pacemaker in place can usually be obtained from the patient's physician [40] . Automatic implantable cardioverter defibrillator devices may get activated without significant warning, potentially causing the patient to perform sudden movements that may result in injury to the patient or the clinician. The placement of a mouth prop should be considered to minimize this potential risk. This is probably less likely to occur with newer devices that initially emit low level bursts followed by stronger electrical shocks if cardioversion does not occur immediately. Epinephrine is contraindicated in all refractory arrhythmias and it should be used with caution (reduced dose with careful monitoring) in patients with pacemakers and implanted defibrillators.
Coronary Artery Disease
Cardiovascular and periodontal diseases are common inflammatory conditions in human population. Atherosclerosis is a diffuse process that starts in early childhood and progresses asymptomatically through adult life [41] . Later on, it is clinically expressed as ischemic coronary syndrome, stroke/transient ischemic stroke and peripheral artery disease. Exposures to infections like periodontal diseases have been postulated to perpetuate inflammatory events in atherogenesis. Recent observational and meta-analysis studies continue to demonstrate a modest but statistically significant increased risk of cardiovascular diseases among persons exposed to periodontal disease or infection. Furthermore, experimental animal models indicate that periodontal infection can increase atherosclerosis in the presence or absence of hypercholesterolemia. Although available pilot data in patients suggests that periodontal treatment can improve serum biomarkers and cardiovascular disease response, the effect of these interventions on true outcomes of cardiovascular diseases like myocardial infarction and stroke is presently unknown [42] . Nevertheless, clinicians and patients should be aware of consistent association between cardiovascular and periodontal diseases along with potential preventive benefits of periodontal interventions. The patient with ischemic heart disease may experience angina pectoris or myocardial infarction [43] .
Myocardial infarction
Myocardial infarction occurs when a narrowed atherosclerotic coronary artery gets acutely occluded leading to necrosis of the heart muscle supplied by that artery. Affected patients generally complain of a crushing substernal pain with radiation to the neck, jaw, or left arm. The pain may be accompanied by shortness of breath, anxiety, nausea and sweating. The highest risk of death following acute myocardial infarction occurs during first 12 hours when the risk of ventricular fibrillation is greatest [44] . Within 6 months following an episode of myocardial infarction, patients are at increased risk of an additional infarction. Consequently, only minimal treatment for acute periodontal problems is advised within 6 months of an episode of myocardial infarction, and preferably after consultation with the patient's physician. Same principles for periodontal treatment are followed as: morning appointments, profound local anesthesia, oral or inhalation sedation (if needed) and close monitoring of the vital signs of the patient.
Hypertension
Hypertension is one of the major risk factors for cardiovascular diseases and a major cause of renal failure and stroke. Blood pressure > 160/95 mm Hg is generally considered as hypertension and 140/90 -160/95 mmHg as borderline for an adult. Periodontists and dental care workers have an important role in the detection and management of hypertensive patients. With routine blood pressure monitoring on different visits, undiagnosed hypertensive patients may be identified and advised to consult a physician. Previously identified hypertensive patients should have their blood pressure taken at each visit. Elective periodontal treatment for uncontrolled hypertensive patients should be deferred until control is achieved. Emergency treatment for uncontrolled hypertensive patients should be as conservative as possible. Some clinical studies have indicated that absorption of sodium bicarbonate, used during periodontal cleaning of tooth surfaces with an air abrasive cleansing device may alter serum electrolyte balance. Any such effects appear minimal and transient. Until now, there is no strong evidence to suggest that use of these substances is contraindicated in patients with cardiovascular disease [45, 46] . The use of epinephrine in combination with local anesthetics is not contraindicated in thehypertensive patient unless the systolic is > 200 and/or diastolic > 115 mmHg. Most authorities recommend small amounts of epinephrine; 0.04 to 0.08 mg/appointment as compared to a maximum of 0.2 mg in a healthy 70 kg adult.Generous local anesthesia is indicated tominimize the release of endogenous epinephrine in response to pain [47] . For prosthodontic treatments, use of vasopressors to control local bleeding and gingival retraction cord containing vasopressors is contraindicated [48] . General anesthesia is not recommended in out-patients with significant hypertensive disease because of the risk of secondary hypertension, and medical advice and care in a hospital setting may be indicated.
Heart Transplantation
Protocols have not yet been established for periodontal or dental management of patients with organ transplants. Active and potential sources of infection (periodontal and dental) should be eliminated and necessary dental care should be accomplished before transplant. Patients who receive a heart transplant on an emergency basis and who have existing and identified dental infection, should receive antibiotics before and after the transplant, until dental treatment is rendered. Following heart transplantation, recipients may be maintained on life long immunosuppressive drugs to blunt the host rejection. These drugs may include cyclosporine, corticosteroides, antilymphocyte globulin (ALG), Azathioprine, or combinations. Periodontists and dental care workers should remain alert for signs and symptoms of unusual systemic fungal infections such as Cryptococcus and mucormycosis. These infections may lead to severe disseminated disease in immunosuppressed patients and must be detected early on for appropriate antimicrobial therapy. Prophylactic antibiotics are recommended for all dental procedures likely to cause bacteremia in transplant patients taking immunosuppressive drugs, and physician consultation is appropriate. For these reasons, mouth wash for one minute with antiseptic at periodontal surgical site may reduce the incidence of possible bacteremia [49] . The use of surgical aspiration can also considerably reduce the bacterial aerosol. Patients under cysclosporine, may harbor gingival enlargement or hyperplasia and gingival surgery is sometimes necessary [50] . Moreover, for patients under adrenal suppressive doses of corticosteroids, supplementary steroids may be necessary prior to stressful periodontal treatments.
